This study was undertaken to evaluate the performance of FAM19A4 and hsa‐mir‐124‐2 hypermethylation as a triage tool for women who are at risk of developing cervical cancer or high‐grade cervical… Click to show full abstract
This study was undertaken to evaluate the performance of FAM19A4 and hsa‐mir‐124‐2 hypermethylation as a triage tool for women who are at risk of developing cervical cancer or high‐grade cervical cancer precursor lesions by taking into consideration the cytology report, histology diagnosis, and human papillomavirus (HPV) status.
               
Click one of the above tabs to view related content.